title: Practical considerations on current guidelines for the management of non-neutropenic adult patients with candidaemia.
abstract: Recent guideline recommendations on the management of candidaemia provide valuable treatment guidance for routine clinical practice, but need to be interpreted in the light of the actual situation of the patient and the local epidemiology of fungal infections. Echinocandins emerge as the generally preferred primary treatment. Treatment should be initiated immediately after notification of a Candida-positive blood culture in all patients. Ambiguous issues include the definition of optimum duration of treatment, the indication and time point to step down to oral azoles, catheter management, and the appropriate approach in critically ill patients at high risk for candidaemia in the absence of definitive proof of infection. Patients with clinical suspicion of antifungal treatment failure need prompt workup for adequacy of treatment, focal sources of sustained infection and potential superinfection.
authors.affiliation: BDH-Klinik Greifswald, Germany. a.gloeckner@bdh-klinik-greifswald.de
authors.forename: A
authors.initials: A
authors.lastname: Glöckner
authors.forename: O A
authors.initials: OA
authors.lastname: Cornely
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D058387:Candidemia / Q000188:drug therapy*; D002405:Catheterization, Central Venous / Q000009:adverse effects; D025141:Drug Resistance, Fungal; D054714:Echinocandins / Q000627:therapeutic use; D006801:Humans; D017410:Practice Guidelines as Topic; D017211:Treatment Failure
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins